Fraser Dove International

🔥 𝐓𝐇𝐈𝐒 𝐉𝐔𝐒𝐓 𝐈𝐍 🔥 The "𝐀𝐜𝐭𝐢𝐯𝐞 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬" podcast is now 𝐋𝐈𝐕𝐄 with our 9th episode starring Vlad Makarenko, VP of HR, Growth Markets at Alfasigma. In this episode, you'll discover: ✅ 𝐓𝐡𝐞 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐭𝐫𝐢𝐚𝐧𝐠𝐥𝐞 𝐟𝐫𝐚𝐦𝐞𝐰𝐨𝐫𝐤 ✅ 𝐇𝐨𝐰 𝐭𝐨 𝐨𝐰𝐧 𝐲𝐨𝐮𝐫 𝐜𝐚𝐫𝐞𝐞𝐫 𝐝𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧 ✅ 𝐓𝐡𝐞 𝐩𝐨𝐰𝐞𝐫 𝐨𝐟 𝐬𝐞𝐞𝐤𝐢𝐧𝐠 𝐝𝐢𝐬𝐜𝐨𝐦𝐟𝐨𝐫𝐭 ✅ 𝐓𝐡𝐞 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐩𝐬𝐲𝐜𝐡𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 ✅ 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐚𝐥 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬 𝐟𝐨𝐫 𝐠𝐥𝐨𝐛𝐚𝐥 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 No more waiting for the "perfect" career formula. No more playing it safe. No more wondering how others made those big leaps. 𝐉𝐮𝐬𝐭 𝐡𝐢𝐭 𝐩𝐥𝐚𝐲 𝐚𝐧𝐝 𝐥𝐢𝐬𝐭𝐞𝐧. (𝐋𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇) https://lnkd.in/e22yE-qA The sooner you start collecting leadership insights, the further ahead you'll be. Already listened? What part hit home for you? #ActiveIngredients #LifeScienceLeadership #NowLive

👇 𝐓𝐡𝐞𝐬𝐞 𝐀𝐫𝐞 𝐘𝐨𝐮𝐫 𝐓𝐨𝐩 𝟓 𝐍𝐞𝐰𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 𝐀𝐫𝐨𝐮𝐧𝐝 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐜𝐭𝐢𝐨𝐧𝐬 & 𝐀𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬 𝐘𝐨𝐮 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐝 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤 👇 1️⃣ Sanofi has received European Commission (EC) approval to use Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for induction treatment in adults newly diagnosed with multiple myeloma (NDMM) who are eligible for stem cell transplantation. This decision is based on the results from part one of the GMMG-HD7 Phase III trial, marking an important regulatory milestone for Sarclisa in the EU. 📰 https://lnkd.in/eGV8kPRw 2️⃣ Moderna has gained a positive recommendation from the European Medicines Agency (EMA) for its updated COVID-19 vaccine targeting the LP.8.1 variant. This endorsement from the Committee for Medicinal Products for Human Use (CHMP) paves the way for marketing authorisation ahead of the 2025–2026 respiratory virus season, pending final approval from the European Commission (EC). 📰 https://lnkd.in/exTwf5sd 3️⃣ The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued several positive recommendations for new treatments across Alzheimer’s disease, HIV prevention, postpartum depression, rare diseases, and cancer. Notably, it reversed a prior negative opinion on Eli Lilly’s Kisunla for Alzheimer’s and endorsed Gilead’s Yeytuo (lenacapavir) for HIV pre-exposure prophylaxis (PrEP), among others. 📰 https://lnkd.in/ebYBXhk9 4️⃣ Roche has secured CE mark approval in Europe under the In Vitro Diagnostic Regulation (IVDR) for its Elecsys pTau181 blood test, the first approved test in the EU designed specifically to rule out Alzheimer’s disease. The test helps primary care doctors identify whether a patient’s cognitive decline is likely unrelated to Alzheimer’s, thereby reducing the need for costly and invasive follow-up diagnostics. 📰 https://lnkd.in/ecxQNm6t 5️⃣ Celcuity has reported strong Phase 3 results for its investigational breast cancer therapy gedatolisib, used in combination with fulvestrant and optionally palbociclib, in patients with PIK3CA wild-type, HR-positive, HER2-negative advanced breast cancer. The positive data clears the way for a planned FDA filing in Q4 2025 and positions the treatment as potentially practice-changing. 📰 https://lnkd.in/ezgrEPvQ #RegulatoryActionsAndApporvals | #LifeSciences | #NewsRoundUp

1️⃣ 𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐠𝐨𝐭 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐢𝐧 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬? 2️⃣ 𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐛𝐮𝐢𝐥𝐭, 𝐥𝐞𝐝 𝐚𝐧𝐝 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐞𝐝 𝐡𝐢𝐠𝐡 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐭𝐞𝐚𝐦𝐬? 3️⃣ 𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐠𝐨𝐭 𝐬𝐭𝐫𝐨𝐧𝐠 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐰𝐢𝐭𝐡 𝐅𝐃𝐀 𝐚𝐧𝐝 𝐄𝐌𝐀? ✅ A resounding, yes? This role could be for you ✅ Fraser Dove International is partnering exclusively with a leading bio organisation. Operating globally, they are committed to ensuring that everyday health remains affordable. As 𝐒𝐢𝐭𝐞 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐇𝐞𝐚𝐝, some of your responsibilities will include continuously assessing Quality processes and systems as well as the regulatory compliance status of products, to proactively identify compliance risks. You will also ensure the site Quality Management System is efficient and aligned with company standards, local and global regulations. 𝐅𝐞𝐞𝐥 𝐫𝐢𝐠𝐡𝐭? 𝐀𝐩𝐩𝐥𝐲 𝐭𝐨𝐝𝐚𝐲 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/eAyk_ZsF Alternatively, contact Peter Vedde for more information on this and similar opportunities with life science organisations in America, Asia, and Europe.

Calling all life science hiring managers, HR Leaders and executives. If your executive team isn't visible online, you're missing out on the top-tier talent that could transform your business. Our Chief Commercial Officer and LinkedIn Top Voice, Andrew MacAskill, is hosting a free Digital Hiring Identity (DHI) workshop for leaders in the life sciences. Expect to learn how to optimise your profile, create content at scale and build online reputation in an efficient way that supercharges hiring. Join Andrew next Monday, 4th August, at 16:15 BST Reserve your spot 👉https://bit.ly/3GR0hE5 #DigitalHiringIdentity #TalentAttraction #LifeSciences

“𝐇𝐞 𝐡𝐚𝐬 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐞𝐞𝐧 𝐚𝐧 𝐞𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐭 𝐭𝐡𝐨𝐮𝐠𝐡𝐭 𝐩𝐚𝐫𝐭𝐧𝐞𝐫 𝐢𝐧 𝐨𝐫𝐠𝐚𝐧𝐢𝐬𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐝𝐞𝐬𝐢𝐠𝐧 𝐚𝐧𝐝 𝐚𝐥𝐰𝐚𝐲𝐬 𝐛𝐫𝐨𝐮𝐠𝐡𝐭 𝐭𝐚𝐥𝐞𝐧𝐭𝐞𝐝 𝐜𝐚𝐧𝐝𝐢𝐝𝐚𝐭𝐞𝐬 𝐟𝐨𝐫𝐰𝐚𝐫𝐝 𝐭𝐨 𝐬𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐭𝐡𝐞 𝐭𝐞𝐚𝐦”. ✅ Consistent partners for our clients ✅ Solid work from our Co-Founder Thomas Dove 😊 #ExecutiveSearch | #LifeSciences | #FraserDove | #Testimonial

✅ 𝐁𝐞𝐥𝐨𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐬 𝐄𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬 𝐭𝐨 𝐌𝐢𝐬𝐬𝐢𝐨𝐧 ✅ Did you manage to tune in to our latest Lift Up Live Broadcast? In this broadcast, ‘𝐂𝐮𝐫𝐚𝐭𝐢𝐧𝐠 𝐂𝐮𝐥𝐭𝐮𝐫𝐞𝐬 𝐨𝐟 𝐁𝐞𝐥𝐨𝐧𝐠𝐢𝐧𝐠 & 𝐈𝐧𝐜𝐥𝐮𝐬𝐢𝐯𝐢𝐭𝐲’, we explored practical techniques to distinguish meaningful inclusion from tick-box exercises in your organisation. To do so, we were privileged to welcome our panel of experts: 🔊 Beth McCormack, MS, PCC, SHRM-SCP, Director Talent Management & Organisational Effectiveness, Hoya Vision Care 🔊 Lisa A. DiPaolo, EVP, CHRO at Karyopharm Therapeutics Inc. 🔊 Jaana Rask, Head of People & Organisation - US Research & Development, Novo Nordisk Here, Lisa expresses that in order to feel like you truly belong at an organisation, you need to be connected to the company’s mission. 👇 𝐈𝐟 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐭𝐡𝐞 𝐛𝐫𝐨𝐚𝐝𝐜𝐚𝐬𝐭 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐭𝐢𝐦𝐞 𝐫𝐨𝐮𝐧𝐝, 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐬𝐭𝐢𝐥𝐥 𝐰𝐚𝐭𝐜𝐡 𝐢𝐭 𝐢𝐧 𝐟𝐮𝐥𝐥 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/ebyTfYu9 #Belonging #Connection #CompanyMission #LiftUp

👇 𝐓𝐡𝐞𝐬𝐞 𝐀𝐫𝐞 𝐘𝐨𝐮𝐫 𝐓𝐨𝐩 𝟓 𝐍𝐞𝐰𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 𝐀𝐫𝐨𝐮𝐧𝐝 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐘𝐨𝐮 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐝 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤 👇 1️⃣ Bain Capital and Botanic Properties have launched a joint venture, GenesisM, aimed at creating a scalable biomanufacturing hub in Bedford, Massachusetts. The project, now under construction, will cater to multiple biotech firms by offering ready-to-use, flexible manufacturing suites that comply with stringent regulatory standards. It’s designed to address major pain points in biotech production: capital expense, construction delays and space limitations. 📰 https://lnkd.in/e2inSub5 2️⃣ This edition of Fierce Pharma Asia highlights a surge in Chinese biotech influence on the global market, with a sharp rise in out licensing deals, landmark acquisitions, and major clinical milestones. Key news includes Takeda’s narcolepsy candidate achieving late-stage trial success, Sino Biopharm’s major acquisition of LaNova Medicines, and ongoing FDA scrutiny of drugmakers over efficacy and manufacturing practices. 📰 https://lnkd.in/eAqZ54vm 3️⃣ Moderna has cancelled plans to build an mRNA drug substance manufacturing plant in Japan, citing an uncertain global and local business environment. Although the company had committed to two facilities at Japan’s iPark in 2023, only a research and development site has been completed. The move reflects broader challenges facing Moderna as it navigates declining vaccine demand, global political uncertainty, and sharp financial pressures. 📰 https://lnkd.in/egTP59xq 4️⃣ Hookipa Pharma has announced plans to liquidate and dissolve the company following the sale of its core assets to Gilead and the collapse of a proposed merger with Poolbeg Pharma. After failing to maintain a sustainable pipeline or secure sufficient value from partnerships, the biotech will delist from Nasdaq and formally shut down operations, pending shareholder approval. 📰 https://lnkd.in/eUwgkQa2 5️⃣ HeartFlow, a U.S.-based developer of artificial intelligence (AI)-driven diagnostics for coronary artery disease, has filed for a $100 million IPO on Nasdaq under the ticker HTFL. This move comes after the company cancelled a $2.4 billion SPAC merger in 2022. With expanded Medicare coverage, improved reimbursement codes, and a growing commercial presence, HeartFlow is positioning itself to re-enter public markets amid a more stable medtech funding environment. 📰 https://lnkd.in/e8Wwtr9W #FinancialDevelopments | #LifeSciences | #NewsRoundUp

1️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬? 2️⃣ 𝐃𝐨 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐭𝐡𝐞 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐯𝐢𝐬𝐢𝐨𝐧 𝐚𝐧𝐝 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐭𝐨 𝐝𝐫𝐢𝐯𝐞 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧? 3️⃣ 𝐂𝐚𝐧 𝐲𝐨𝐮 𝐥𝐞𝐚𝐝 𝐠𝐥𝐨𝐛𝐚𝐥 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐢𝐧 𝐯𝐢𝐫𝐚𝐥 𝐯𝐞𝐜𝐭𝐨𝐫 𝐚𝐧𝐝 𝐦𝐑𝐍𝐀 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠? ✅ A resounding, yes? This role could be for you ✅ Fraser Dove International is partnering exclusively with a leading biologics CDMO organisation. Operating globally, they are committed to transforming the development and manufacturing of advanced therapeutics. As 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐕𝐏 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬, some of your responsibilities will include leading global teams in viral vector and plasmid process development. You will also define and implement MSAT strategy and technology transfer processes. 𝐅𝐞𝐞𝐥 𝐫𝐢𝐠𝐡𝐭? 𝐀𝐩𝐩𝐥𝐲 𝐭𝐨𝐝𝐚𝐲 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/eaACQ9nS Alternatively, contact Peter Vedde for more information on this and similar opportunities with life science organisations in America, Asia, and Europe. #GlobalSVPTechnicalOperations #LifeSciences #FraserDove #RoleOfTheWeek

“𝐈 𝐟𝐞𝐥𝐭 𝐰𝐞𝐥𝐥 𝐭𝐚𝐤𝐞𝐧 𝐜𝐚𝐫𝐞 𝐨𝐟 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐩𝐫𝐨𝐜𝐞𝐬𝐬”. ✅ Showing our customers some TLC ✅ Another enjoyable experience for our candidates 😊 #ExecutiveSearch | #LifeSciences | #FraserDove | #Testimonial

🔥 𝐉𝐔𝐒𝐓 𝐀𝐑𝐑𝐈𝐕𝐄𝐃 🔥 The "𝐀𝐜𝐭𝐢𝐯𝐞 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬" podcast is now 𝐋𝐈𝐕𝐄 with our 8th episode starring Audrey Greenberg, CEO at AG Capital. In this episode, you'll discover: ✅ 𝐇𝐨𝐰 𝐂-𝐬𝐮𝐢𝐭𝐞 𝐚𝐮𝐭𝐡𝐞𝐧𝐭𝐢𝐜𝐢𝐭𝐲 𝐛𝐫𝐞𝐞𝐝𝐬 𝐭𝐫𝐮𝐬𝐭 𝐚𝐧𝐝 𝐫𝐞𝐬𝐩𝐞𝐜𝐭 ✅ 𝐓𝐡𝐞 𝐩𝐨𝐰𝐞𝐫 𝐨𝐟 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐟𝐥𝐞𝐱𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐢𝐧 𝐭𝐨𝐝𝐚𝐲’𝐬 𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 ✅ 𝐖𝐡𝐲 𝐩𝐮𝐭𝐭𝐢𝐧𝐠 𝐩𝐞𝐨𝐩𝐥𝐞 𝐟𝐢𝐫𝐬𝐭 𝐝𝐫𝐢𝐯𝐞𝐬 𝐬𝐮𝐜𝐜𝐞𝐬𝐬 𝐢𝐧 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐚𝐧𝐝 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 ✅ 𝐇𝐨𝐰 𝐜𝐮𝐫𝐢𝐨𝐬𝐢𝐭𝐲 𝐚𝐧𝐝 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐞 𝐜𝐚𝐫𝐞𝐞𝐫 𝐠𝐫𝐨𝐰𝐭𝐡 𝐟𝐨𝐫 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞𝐬 ✅ 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐚𝐥 𝐦𝐞𝐭𝐡𝐨𝐝𝐬 𝐟𝐨𝐫 𝐦𝐚𝐤𝐢𝐧𝐠 𝐛𝐨𝐥𝐝 𝐜𝐚𝐫𝐞𝐞𝐫 𝐭𝐫𝐚𝐧𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡𝐢𝐧 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 No more waiting for the "perfect" career formula. No more playing it safe. No more wondering how others made those big leaps. 𝐉𝐮𝐬𝐭 𝐡𝐢𝐭 𝐩𝐥𝐚𝐲 𝐚𝐧𝐝 𝐥𝐢𝐬𝐭𝐞𝐧. (𝐋𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇) https://lnkd.in/eAqfcp4Y The sooner you start collecting leadership insights, the further ahead you'll be. Already listened? What part hit home for you? #ActiveIngredients #LifeScienceLeadership #NowLive